Second line chemotherapy using gemcitabine and docetaxel for soft tissue sarcoma
Phase 2
- Conditions
- soft tissue sarcoma except for small round cell tumor
- Registration Number
- JPRN-UMIN000015917
- Lead Sponsor
- Gifu University school of medicine
- Brief Summary
o participant.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
Not provided
Exclusion Criteria
patient who doesn't show his/her assent patient considered to be not suitable for participating this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method reduction of tumor volume
- Secondary Outcome Measures
Name Time Method adverse effect